Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen filed an amended beneficial ownership statement with the SEC on November 13, 2026, disclosing their combined holdings in Immatics N.V. ordinary shares as of the event date of September 30, 2026.

Key Highlights

  • Montanova Capital and Aaron Cowen: each reported beneficial ownership of 8,750,816 ordinary shares of Immatics N.V., representing 5.8% of the class.
  • Averill Master Fund, Ltd.: reported beneficial ownership of 7,464,908 ordinary shares, representing 4.99% of the class.
  • Shared voting and dispositive power only: all three reporting persons reported zero sole voting power and zero sole dispositive power, with all shares held on a shared basis.
  • Advisory clients as direct owners: the filing states that all reported securities are directly owned by advisory clients of Montanova Capital, LLC, and that none of those clients individually owns more than 5% of the class.
  • Amendment No. 4: this filing updates a prior beneficial ownership statement, triggered by an event dated September 30, 2026.
  • CUSIP N44445109: the securities covered are ordinary shares with a nominal value of euro 0.01 per share.

Montanova Capital and Cowen Disclose Shared Holdings in Immatics Ordinary Shares

According to the filing, Montanova Capital, LLC, a Delaware-organized investment adviser, and Aaron Cowen, identified as a holding company or control person and an individual, each reported aggregate beneficial ownership of 8,750,816 ordinary shares of Immatics N.V. (NASDAQ:IMTX), equal to 5.8% of the outstanding class. Immatics N.V., whose principal executive offices are located at Paul Ehrlich-strasse 15, 72076 Tubingen, Federal Republic of Germany, is the issuer of the reported securities. The company is engaged in the development of T cell-redirecting cancer immunotherapies.

The filing discloses that Averill Master Fund, Ltd., organized in the Cayman Islands, separately reported beneficial ownership of 7,464,908 shares, or 4.99% of the class. All three reporting persons certified that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of changing or influencing control of Immatics N.V. The filing further states that "all of the securities reported in this Schedule 13G Amendment No. 4 are directly owned by advisory clients of Montanova Capital, LLC" and that "none of those advisory clients may be deemed to beneficially own more than 5% of the ordinary shares."

Each reporting person also noted, in comments accompanying their signatures, that they "disclaim beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein." The filing was signed by Andrew Nathanson, General Counsel and Chief Compliance Officer, on behalf of both Montanova Capital, LLC and Averill Master Fund, Ltd., and by Aaron Cowen individually, each on November 13, 2026.

What Was Disclosed

Three reporting persons - Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen - filed an amended beneficial ownership disclosure covering Immatics N.V. ordinary shares, reporting shared voting and dispositive power over 8,750,816 and 7,464,908 shares respectively, as of September 30, 2026.